Riluzole is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Quinn Pharmaceuticals, Llc. The primary component is Riluzole.
Product ID | 69076-611_d58c2bdc-ee77-4976-833d-0eff4cf78b79 |
NDC | 69076-611 |
Product Type | Human Prescription Drug |
Proprietary Name | Riluzole |
Generic Name | Riluzole |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-01-14 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA204430 |
Labeler Name | Quinn Pharmaceuticals, Llc |
Substance Name | RILUZOLE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Benzothiazole [EPC],Benzothiazoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2019-01-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA204430 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-14 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
RILUZOLE | 50 mg/1 |
SPL SET ID: | d58c2bdc-ee77-4976-833d-0eff4cf78b79 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-4145 | Riluzole | riluzole |
42291-775 | Riluzole | riluzole |
60505-3285 | RILUZOLE | RILUZOLE |
62756-538 | Riluzole | Riluzole |
64980-191 | Riluzole | riluzole |
67877-286 | Riluzole | Riluzole |
68084-908 | RILUZOLE | RILUZOLE |
68462-381 | riluzole | riluzole |
69076-200 | Riluzole | riluzole |
69076-611 | Riluzole | Riluzole |
10094-350 | EXSERVAN | riluzole |
70510-2201 | Exservan | riluzole |
70510-2202 | Exservan | riluzole |
70515-700 | Rilutek | riluzole |
70726-0303 | TIGLUTIK | Riluzole |